FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)

Lobbying for SKYHAWK THERAPEUTICS, INC. · Biotech company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $90,000.00 income · posted Apr 14, 2026

Lobbying activity 1

Health Issues

Lobbying related to rare disease innovation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem